Fu-Chun Li

8PUBLICATIONS
21CO-AUTHORS
HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCardiology (incl. cardiovascular diseases)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 15, 2024
Correction: Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group.

Lan-Ping Xu, Pei-Hua Lu, De-Pei Wu

|Sep 25, 2024
Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group.

Lan-Ping Xu, Pei-Hua Lu, De-Pei Wu

|Oct 18, 2022
Fludarabine- and low-dose cyclophosphamide-based conditioning regimens provided favorable survival and engraftment for unmanipulated hematopoietic cell transplantation from unrelated donors and matched siblings in patients with Fanconi anemia: results from the CBMTR.

Lanping Xu, Yue Lu, Jing Chen

|Sep 23, 2022
Characteristics of anti-CLL1 based CAR-T therapy for children with relapsed or refractory acute myeloid leukemia: the multi-center efficacy and safety interim analysis.

Hui Zhang, Chaoke Bu, Zhiyong Peng

|Aug 21, 2022
Unmanipulated haploidentical haematopoietic cell transplantation with radiation-free conditioning in Fanconi anaemia: A retrospective analysis from the Chinese Blood and Marrow Transplantation Registry Group.

Lanping Xu, Yue Lu, Shaoyan Hu

|Aug 26, 2021
Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group.

Lan-Ping Xu, Pei-Hua Lu, De-Pei Wu

Pageof 2

Frequent Collaborators

4 joint publications

Xiaojun Huang

4 joint publications

Lanping Xu

3 joint publications

Xi Zhang

3 joint publications

Dai-Hong Liu